Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/07/2001 | EP1151106A2 Methods for producing polypeptides in fungal cells |
11/07/2001 | EP1151105A1 Neisseria meningitidis serogroup b antigen |
11/07/2001 | EP1151104A1 Diagnostic and protective antigen gene sequences of ichthyophthirius |
11/07/2001 | EP1151103A1 Nac1 - a plant gene encoding a transcription factor involved in cotyledon and lateral root development |
11/07/2001 | EP1151102A1 Glycosylated leptin compositions and related methods |
11/07/2001 | EP1151101A1 Prostacyclin-stimulating factor-2 |
11/07/2001 | EP1151100A1 Tau-conotoxin peptides |
11/07/2001 | EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
11/07/2001 | EP1151098A1 Malaria vaccine |
11/07/2001 | EP1151097A1 Haemophilus influenzae rd outer membrane sequences used as vaccine |
11/07/2001 | EP1151096A2 Prostate, testis and uterine polypeptide zpep14 |
11/07/2001 | EP1151095A1 Polypeptide variants with raised heparin-binding capacity |
11/07/2001 | EP1151094A1 Cervical cancer treatment |
11/07/2001 | EP1151009A2 Antimicrobial/endotoxin neutralizing polypeptide |
11/07/2001 | EP1151008A1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
11/07/2001 | EP1151007A1 A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method |
11/07/2001 | EP1151006A1 Human g protein coupled receptor |
11/07/2001 | EP1151005A1 Peptide variants of the tumour marker muc1 and the use thereof |
11/07/2001 | EP1151004A1 Method for producing il-1ra, a therapeutically active protein from body fluids |
11/07/2001 | EP1151003A1 Novel fibronectin-binding protein |
11/07/2001 | EP1151001A2 Method for altering undesirable immune responses to polypeptides |
11/07/2001 | EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
11/07/2001 | EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
11/07/2001 | EP1150942A1 Improved compounds for protein binding |
11/07/2001 | EP1150714A2 Methods for inhibiting brain tumor growth |
11/07/2001 | EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules |
11/07/2001 | EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
11/07/2001 | EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
11/07/2001 | EP1150701A2 Homing pro-apoptotic conjugates and methods of using same |
11/07/2001 | EP1150700A1 Antiangiogenic drugs |
11/07/2001 | EP1150699A1 Treatment of bladder and gastrointestinal mastocytosis |
11/07/2001 | EP1150698A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
11/07/2001 | EP1150696A2 Treatment of tumors with genetically engineered herpes virus |
11/07/2001 | EP1150693A1 Immunogenic compositions for use as vaccines |
11/07/2001 | EP1150691A2 Novel antisense inhibition of rad51 |
11/07/2001 | EP1150688A1 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
11/07/2001 | EP0824699B1 Compounds and methods for diagnosis of leishmaniasis |
11/07/2001 | EP0820526B1 Coding sequences of the human brca1 gene |
11/07/2001 | EP0815139B1 Thrombin inhibitors based on the amino acid sequence of hirudin |
11/07/2001 | EP0783693B1 In vitro models of cns function and dysfunction |
11/07/2001 | EP0689596B1 Stimulation of immune response by viral protein |
11/07/2001 | EP0651768B1 USE OF p97 IN THE DIAGNOSIS OF ALZHEIMER DISEASE |
11/07/2001 | EP0546108B1 Pro-drugs for cck antagonists |
11/07/2001 | EP0429538B1 Plant elongation factor, promoters, coding sequences and uses |
11/07/2001 | CN1321192A Novel strains of bacillus subtilis group for food fermentation |
11/07/2001 | CN1321191A Pi-ta gene conferring disease resistance to plants |
11/07/2001 | CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene |
11/07/2001 | CN1321168A Laundry detergent and/or fabric care compositions comprising modified antimicrobial protein |
11/07/2001 | CN1321167A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of HLA |
11/07/2001 | CN1321165A Prevention and treatment of viral disease |
11/07/2001 | CN1321164A Nucleic acids encoding G protein gamma subunit involved in sensory transduction |
11/07/2001 | CN1321091A Method of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
11/07/2001 | CN1321064A Plant resistance to insect pests medicated by viral proteins |
11/07/2001 | CN1320691A Polypeptide-human nucleotide reductase 9 and polynucleotide for coding it |
11/07/2001 | CN1320689A Expression system using autotomy of fusion protein, and reduced polypeptide |
11/07/2001 | CN1320642A Polypeptide-human zinc finger protein 28 and polynucleotide for coding it |
11/07/2001 | CN1320641A Polypeptide-human HS1 protein 16 and polynucleotide for coding it |
11/07/2001 | CN1320640A Polypeptide-human III-type main tissue compatible protein compound 11 and polynucleotide for coding it |
11/07/2001 | CN1320639A Polypeptide-human protein 9 containing characteristic sequence fragment of ribosomal protein L19 and polynucleotide for coding it |
11/07/2001 | CN1320638A Polypeptide-human apoptosis regulatory protein 11 and polynucleotide for coding it |
11/07/2001 | CN1320637A Polypeptide-human somatotropic hormone 11 and polynucleotide for coding it |
11/07/2001 | CN1320636A Polypeptide-human protein 9 containing porin characteristic sequence fragment and polynucleotide for coding it |
11/07/2001 | CN1320635A Polypeptide-human protein 9 containing P5CR characteristic sequence fragment and polynucleotide for coding it |
11/07/2001 | CN1320634A Polypeptide-human protein 20 containing pairing coassette structural domain and polynucleotide for coding it |
11/07/2001 | CN1320633A Polypeptide-human movin-like protein 14 and polynucleotide for coding it |
11/07/2001 | CN1320631A Polypeptide-human protein 10 containing cellulose binding structural domain and polynucleotide for coding it |
11/07/2001 | CN1320630A Polypeptide-human nucleolar phosphoprotein 13 and polynucleotide for coding it |
11/07/2001 | CN1320629A Polypeptide-human insulin-like growth factor bindin 9 and polynucleotide for coding it |
11/07/2001 | CN1320628A Polypeptide-human alpha-catenin associated protein 9 and polynucleotide for coding it |
11/07/2001 | CN1320627A Polypeptide-human renal cancer RAGE4 antigen 22 and polynucleotide for coding it |
11/07/2001 | CN1320626A Polypeptide-human renal cancer RAGE4 antigen 25 and polynucleotide for coding it |
11/07/2001 | CN1320624A Polypeptide-human Pax protein 9.9 and polynucleotide for coding it |
11/07/2001 | CN1320623A Polypeptide-human protein 11 conservative domain containing G protein coupled receptor and polynucleotide for coding it |
11/07/2001 | CN1320622A Polypeptide-human beta-globulin regulatory factor 10 and polynucleotide for coding it |
11/07/2001 | CN1320621A Polypeptide-human zinc ion transporter 26 and polynucleotide for coding it |
11/07/2001 | CN1320620A Polypeptide-human Pax protein 19 and polynucleotide for coding it |
11/07/2001 | CN1320619A Polypeptide-human gap junction protein 9 and polynucleotide for coding it |
11/07/2001 | CN1320618A Polypeptide-human Pax protein 12.5 and polynucleotide for coding it |
11/07/2001 | CN1320617A Polypeptide-human Pax protein 14 and polynucleotide for coding it |
11/07/2001 | CN1320616A Polypeptide-human Pax protein 17 and polynucleotide for coding it |
11/07/2001 | CN1320615A Polypeptide-human Pax protein 16 and polynucleotide for coding it |
11/07/2001 | CN1320614A Polypeptide-human translation initiation factor accessory factor 81 and polynucleotide for coding it |
11/07/2001 | CN1320613A Polypeptide-human ribosome S7 protein 14 and polynucleotide for coding it |
11/07/2001 | CN1320612A Human vesicular monoamine transporter and its coding sequence |
11/07/2001 | CN1320611A Polypeptide-cytokine receptor 15 and polynucleotide for coding it |
11/07/2001 | CN1320610A Polypeptide-G-beta similar protein 29 and polynucleotide for coding it |
11/07/2001 | CN1320609A Polypeptide-CYP-60-18 and polynucleotide for coding it |
11/07/2001 | CN1320608A Polypeptide-laminin 16 and polynucleotide for coding it |
11/07/2001 | CN1320607A Polypeptide-laminin 19 and polynucleotide for coding it |
11/07/2001 | CN1320426A Compound for treatment of female sexual dysfuction |
11/07/2001 | CN1074458C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
11/07/2001 | CN1074422C Method for preparing HCV epitope-contg. separated polypeptide |
11/06/2001 | US6313378 Transgenic plant for use in biological pest control |
11/06/2001 | US6313376 Nucleotide sequences coding membrane protein; for generation of plants which are desication, brine, freeze and/or drought resistant |
11/06/2001 | US6313375 Maize aquaporins and uses thereof |
11/06/2001 | US6313373 Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals |
11/06/2001 | US6313283 Expression system for altered expression levels |
11/06/2001 | US6313281 Nucleic acid encoding OMP26 antigen from Haemophilus influenzae |
11/06/2001 | US6313280 Suppresses brachyury-mediated transcription activation; hybrid screening assays; zinc finger domains; genetic engineering and expression |
11/06/2001 | US6313279 Nucleotide sequences coding neurotransmitter; for use in treatment of brain disorders |